Orotic Acid

Orotic Acid

SCHEMBL185887

O=C(O)c1cc(O)nc(O)n1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.50
TSHR P16473 2/20 0.50
HIF1A Q16665 1/20 0.50
KDM4E B2RXH2 6/20 0.41
TDP1 Q9NUW8 2/20 0.41
ACMSD Q8TDX5 1/20 0.41
HCAR2 Q8TDS4 6/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM6B O15054 1/20 0.39
TET3 O43151 1/20 0.39
KDM4A O75164 1/20 0.39
BBOX1 O75936 1/20 0.39
MAPT P10636 1/20 0.39
KDM5A P29375 1/20 0.39
KDM5C P41229 1/20 0.39
ASPH Q12797 1/20 0.39
KDM4D Q6B0I6 1/20 0.39
TET2 Q6N021 1/20 0.39
ALKBH5 Q6P6C2 1/20 0.39
KDM7A Q6ZMT4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705265 0.87 ALOX15 (0.56) ALOX15TSHRHIF1AKDM4ETDP1
Orotic Acid SCHEMBL9443769 0.85 KDM4E (0.46) ALOX15TSHRHIF1AKDM4ETDP1
Orotic Acid SCHEMBL28231800 0.81 ALOX15 (0.35) ALOX15TSHRHIF1A
SCHEMBL11013946 0.81 ALOX15 (0.30) ALOX15TSHRHIF1A
SCHEMBL12086579 0.79 LMNA (0.31) LMNA
SCHEMBL10479187 0.79 ALOX15 (0.48) ALOX15TSHRHIF1AKDM4ETDP1
SCHEMBL3455658 0.79 LMNA (0.50) TSHRKDM4EALDH1A1LMNA
SCHEMBL14537021 0.79 ALDH1A1 (0.39) ALDH1A1MAPTSMN1; SMN2
SCHEMBL6301920 0.77 HIF1A (0.46) ALOX15TSHRHIF1AKDM4ETDP1
SCHEMBL8626403 0.77 ALOX15 (0.46) ALOX15TSHRHIF1AKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138879-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH KISUMA CHEMICALS B V (NL) 2026-05-21 US claimed
EP-4605346-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH Kisuma Chemicals B.V. (NL) 2025-08-27 EP claimed
WO-2024085755-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH KISUMA CHEMICALS B.V. (NL) 2024-04-25 WO claimed
CN-109761916-A A kind of improvement synthetic method of orotic acid 成都百事兴科技实业有限公司 2019-05-17 CN claimed
EP-3084042-B1 DEPOSITION OF COPPER-TIN AND COPPER-TIN-ZINC ALLOYS FROM AN ELECTROLYTE UMICORE GALVANOTECHNIK GMBH (DE) 2018-11-07 EP claimed
US-20160348259-A1 DEPOSITION OF COPPER-TIN AND COPPER-TIN-ZINC ALLOYS FROM AN ELECTROLYTE UMICORE GALVANOTECHNIK GMBH (DE) 2016-12-01 US claimed
CN-101467968-A Preparation for novel administration route of antiarrhythmic medicament ZHEJIANG ZHENGFANG PHARMACEUTI (CN) 2009-07-01 CN claimed
US-20260138879-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH KISUMA CHEMICALS B V (NL) 2026-05-21 US disclosed
EP-4605346-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH Kisuma Chemicals B.V. (NL) 2025-08-27 EP disclosed
WO-2024085755-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH KISUMA CHEMICALS B.V. (NL) 2024-04-25 WO disclosed
CN-112779303-B Method for synthesizing orotic acid by biological enzyme method 华东理工大学 2023-05-02 CN disclosed
US-20230096028-A1 BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF Revolution Medicines, Inc. 2023-03-30 US disclosed
EP-3930845-A1 BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF Revolution Medicines, Inc. (US) 2022-01-05 EP disclosed
WO-1992020816-A1 DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF YALE UNIVERSITY (US) 1992-11-26 WO disclosed
US-4873228-A 2-oxo-4-carboxy-pyrimidines and their use as anti-malaria and anti-cancer agents THE UNIVERSITY OF MELBOURNE (AU) 1989-10-10 US disclosed
EP-0260057-A2 2-Oxo-4-carboxy-pyrimidines THE UNIVERSITY OF MELBOURNE (AU) 1988-03-16 EP disclosed
US-4689328-A CARBOXY-PYRIMIDINE DERIVATIVES RESEARCH CORPORATION (US) 1987-08-25 US disclosed
US-4508723-A 6-Azaoligocycloalkylmethyleneaminopenam compounds CIBA GEIGY CORPORATION (US) 1985-04-02 US disclosed
US-4495201-A Pharmaceutical composition and method for treating heart diseases therewith INSTITUT ORGANICHESKOI KHIMII IMENI N.D. ZELINSKOGO (SU) 1985-01-22 US disclosed
US-4430495-A Process for preparing lincomycin and clindamycin ribonucleotides THE UPJOHN COMPANY (US) 1984-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230096028-A1 BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF SOST, SOS1, IQGAP1 ALOX15 2579/4885TSHR 4035/4885HIF1A 1142/4885
US-20260138879-A1 MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH LDHA, LDHB, ME2 ALOX15 959/4885TSHR 4832/4885HIF1A 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.